default author photo

Julia Braun

University of Zurich - Epidemiology, Biostatistics and Prevention Institute (EBPI)

SCHOLARLY PAPERS

1

DOWNLOADS

181

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

A Living Benefit-Harm Modelling Study of Glp-1 Receptor Agonists for Weight Reduction in Non-Diabetic Obese and Overweight Individuals

Number of pages: 20 Posted: 01 Feb 2024
Hannah Moll, Eliane Frey, Philipp Gerber, Bettina Geidl, Marco Kaufmann, Julia Braun, Felix Beuschlein, Milo A. Puhan and Henock G. Yebyo
University of Zurich - Epidemiology, Biostatistics and Prevention Institute (EBPI), ETH Zürich - Department of Chemistry and Applied Biosciences, University of Zurich, University of Zurich, University of Zurich - Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich - Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich, University of Zurich - Epidemiology, Biostatistics and Prevention Institute (EBPI) and University of Zurich - Epidemiology, Biostatistics and Prevention Institute (EBPI)
Downloads 181 (418,025)

Abstract:

Loading...

Obesity, Overweight, Metabolic disease, GLP-1 RA, Weight loss, Weight management, Benefit-harm assessment